Lyme Disease Diagnostic Study

Lyme disease, a systemic tick-borne infection caused by bacteria Borrelia burgdorferi, is the most common vector-borne disease in the USA. The current Centers for Disease Control and Prevention-approved diagnostic methods to detect Lyme disease are inaccurate in the early stages of the disease, as they rely on the detection of a host antibody response that often takes 3 weeks or more to develop. A diagnostic test to directly measure B. burgdorferi in the blood would significantly enhance the detection of Lyme disease in the early stages, when treatment is most effective.

The Department of Pathology Research is working to develop a very sensitive and specific assay for an early direct detection of B. burgdorferi from blood of Lyme disease patients. Currently, we are seeking individuals who have been recently diagnosed with Lyme disease to participate in our study.

  • 18 years of age or older
  • Newly diagnosed with Lyme disease by healthcare provider
  • Antibiotic treatment not greater than 72 hours
  • Answer a series of questions about your Lyme disease history
  • Donate about two tablespoons of blood
  • Participation in this study requires two additional visits to the study site for follow up blood draws
  • Compensation given upon completion of all three study visits

If you have recently been diagnosed with Lyme disease and have not been on antibiotic treatment for more than 72 hours, please call 203-739-8383 or email to discuss your possible participation in this study.